ENDO HEALTH SOLUTIONS INC. 4
4 · ENDO HEALTH SOLUTIONS INC. · Filed Mar 3, 2014
Insider Transaction Report
Form 4
Smith Jill D.
Director
Transactions
- Disposition to Issuer
2010 Stock Incentive Plan Restricted Stock Units (RSU)
2014-02-28−6,515→ 0 total - Disposition to Issuer
Common Stock, par value, $.01 per share
2014-02-28−3,084→ 0 total
Footnotes (2)
- [F1]On February 28, 2014, Endo Health Solutions, Inc. ("Endo") and Paladin Laboratories Inc. ("Paladin") consummated a transaction under an arrangement agreement pursuant to which each of Endo and Paladin was acquired by a new Irish holding company, Endo International plc ("New Endo"). Under the terms of the arrangement agreement (a) New Endo acquired Paladin pursuant to a plan of arrangement under Canadian law and (b) a newly formed subsidiary of New Endo merged with and into Endo, with Endo as the surviving corporation in the merger (the "Merger") and an indirect wholly owned subsidiary of New Endo. At the effective time of the Merger, each Endo common share was cancelled and converted into the right to receive one New Endo ordinary share. The number here represents shares of Endo disposed of pursuant to the Merger.
- [F2]These restricted stock units granted on March 12, 2013 under the 2010 Stock Incentive Plan, which vest 100% on March 12, 2014, were assumed by New Endo in the Merger and converted into New Endo restricted stock units with the same terms and conditions as the original Endo restricted stock units.